Progress in imaging the effects of psychosis susceptibility gene variants

Expert Review of Neurotherapeutics

Volumn 13, Issue 1, 2013, Pages 37-47

  Redpath, Holly L ^a   Lawrie, Stephen M ^a   Sprooten, Emma ^a   Whalley, Heather C ^a   McIntosh, Andrew M ^a   Hall, Jeremy ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

DISC1; fMRI; genetic imaging; NRG1; psychosis; schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

DISC1 GENE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE; GENE INTERACTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; MOLECULAR MECHANICS; NEUROIMAGING; NRG1 GENE; REVIEW; SCHIZOPHRENIA;

BRAIN; DIAGNOSTIC IMAGING; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NERVE TISSUE PROTEINS; NEUREGULIN-1; PSYCHOTIC DISORDERS;

EID: 84871585909     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.12.145     Document Type: Review

References (93)

1. Glahn DC, Paus T, Thompson PM. Imaging genomics: mapping the influence of genetics on brain structure and function. Hum. Brain Mapp. 28(6), 461-463 (2007).
2. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psychiatry 172, 110-120 (1998).
3. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr. Res. 49(1-2), 1-52 (2001).
4. Frith CD, Friston KJ, Herold S et al. Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. Br. J. Psychiatry 167(3), 343-349 (1995).
5. Lander ES, Linton LM, Birren B et al.; International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 409(6822), 860-921 (2001).
6. Rodriguez-Murillo L, Gogos JA, Karayiorgou M. The genetic architecture of schizophrenia: new mutations and emerging paradigms. Annu. Rev. Med. 63, 63-80 (2012).
7. Hariri AR, Weinberger DR. Imaging genomics. Br. Med. Bull. 65, 259-270 (2003).
8. Blasi G, Bertolino A. Imaging genomics and response to treatment with antipsychotics in schizophrenia. NeuroRx 3(1), 117-130 (2006).
9. Kempf L, Meyer-Lindenberg A. Imaging genetics and psychiatry. Focus 4(3), 327 (2006).
10. Sawa A, Snyder SH. Schizophrenia: diverse approaches to a complex disease. Science 296(5568), 692-695 (2002).
11. Stefansson H, Rujescu D, Cichon S et al.; GROUP. Large recurrent microdeletions associated with schizophrenia. Nature 455(7210), 232-236 (2008).
12. Harrison PJ, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361(9355), 417-419 (2003).
13. Buchman DZ, Illes J. Neuroscience: imaging genetics for our neurogenetic future. Minn. JL Sci. Tech. 11(1), 79-97 (2010).
14. Bearden CE, van Erp TG, Thompson PM, Toga AW, Cannon TD. Cortical mapping of genotype-phenotype relationships in schizophrenia. Hum. Brain Mapp. 28(6), 519-532 (2007).
15. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 7(10), 818-827 (2006).
16. McIntosh AM, Baig BJ, Hall J et al. Relationship of catechol-O- methyltransferase variants to brain structure and function in a population at high risk of psychosis. Biol. Psychiatry 61(10), 1127-1134 (2007).
17. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160(4), 636-645 (2003).
18. Allen AJ, Griss ME, Folley BS, Hawkins KA, Pearlson GD. Endophenotypes in schizophrenia: a selective review. Schizophr. Res. 109(1), 24-37 (2009).
19. Weiss AP, Schacter DL, Goff DC et al. Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia. Biol. Psychiatry 53(1), 48-55 (2003).
20. Honey GD, Bullmore ET, Sharma T. De-coupling of cognitive performance and cerebral functional response during working memory in schizophrenia. Schizophr. Res. 53(1-2), 45-56 (2002).
21. Hyde LW, Bogdan R, Hariri AR. Understanding risk for psychopathology through imaging gene-environment interactions. Trends Cogn. Sci. (Regul. Ed.) 15(9), 417-427 (2011).
22. Lee KW, Woon PS, Teo YY, Sim K. Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt? Neurosci. Biobehav. Rev. 36(1), 556-571 (2012).
23. O'Donovan MC, Craddock N, Norton N et al.; Molecular Genetics of Schizophrenia Collaboration. Identification of loci associated with schizophrenia by genomewide association and follow-up. Nat. Genet. 40(9), 1053-1055 (2008).
24. Esslinger C, Walter H, Kirsch P et al. Neural mechanisms of a genome-wide supported psychosis variant. Science 324(5927), 605 (2009).
25. Mössner R, Schuhmacher A, Wagner M et al. The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms. Eur. Arch. Psychiatry Clin. Neurosci. 262(3), 193-197 (2012).
26. Porteous DJ, Thomson P, Brandon NJ, Millar JK. The genetics and biology of DISC1-an emerging role in psychosis and cognition. Biol. Psychiatry 60(2), 123-131 (2006).
27. Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK. The DISC locus in psychiatric illness. Mol. Psychiatry 13(1), 36-64 (2008).
28. Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 60(2), 132-140 (2006).
29. Woo RS, Li XM, Tao Y et al. Neuregulin-1 enhances depolarization-induced GABA release. Neuron 54(4), 599-610 (2007).
30. Ayalew M, Le-Niculescu H, Levey DF et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol. Psychiatry 17(9), 887-905 (2012).
31. Blackwood DH, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 69(2), 428-433 (2001).
32. St Clair D, Blackwood D, Muir W et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336(8706), 13-16 (1990).
33. Mao Y, Ge X, Frank CL et al. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3β/β-catenin signaling. Cell 136(6), 1017-1031 (2009).
34. Brandon NJ, Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat. Rev. Neurosci. 12(12), 707-722 (2011).
35. Porteous DJ, Millar JK, Brandon NJ, Sawa A. DISC1 at 10: connecting psychiatric genetics and neuroscience. Trends Mol. Med. 17(12), 699-706 (2011).
36. Ma L, Liu Y, Ky B, Shughrue PJ, Austin CP, Morris JA. Cloning and characterization of Disc1, the mouse ortholog of DISC1 (disrupted-in- schizophrenia 1). Genomics 80(6), 662-672 (2002).
37. Callicott JH, Straub RE, Pezawas L et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc. Natl Acad. Sci. USA 102(24), 8627-8632 (2005).
38. Schurov IL, Handford EJ, Brandon NJ, Whiting PJ. Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol. Psychiatry 9(12), 1100-1110 (2004).
39. Callicott JH, Egan MF, Mattay VS et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am. J. Psychiatry 160(4), 709-719 (2003).
40. Hariri AR, Goldberg TE, Mattay VS et al. Brain-derived neurotrophic factor val66met polymorphism affects human memoryrelated hippocampal activity and predicts memory performance. J. Neurosci. 23(17), 6690-6694 (2003).
41. Egan MF, Goldberg TE, Kolachana BS et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl Acad. Sci. USA 98(12), 6917-6922 (2001).
42. DeRosse P, Hodgkinson CA, Lencz T et al. Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia. Biol. Psychiatry 61(10), 1208-1210 (2007).
43. Fanous AH, Kendler KS. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol. Psychiatry 10(1), 6-13 (2005).
44. Di Giorgio A, Blasi G, Sambataro F et al. Association of the SerCys DISC1 polymorphism with human hippocampal formation gray matter and function during memory encoding. Eur. J. Neurosci. 28(10), 2129-2136 (2008).
45. Hennah W, Thomson P, McQuillin A et al. DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol. Psychiatry 14(9), 865-873 (2009).
46. Gur RE, Keshavan MS, Lawrie SM. Deconstructing psychosis with human brain imaging. Schizophr. Bull. 33(4), 921-931 (2007).
47. Prata DP, Mechelli A, Fu CH et al. Effect of disrupted-in-schizophrenia-1 on pre-frontal cortical function. Mol. Psychiatry 13(10), 915-917, 909 (2008).
48. Prata DP, Mechelli A, Picchioni M et al. No association of disrupted-in-schizophrenia-1 variation with prefrontal function in patients with schizophrenia and bipolar disorder. Genes Brain Behav. 10(3), 276-285 (2011).
49. Sprooten E, Sussmann JE, Moorhead TW et al. Association of white matter integrity with genetic variation in an exonic DISC1 SNP. Mol. Psychiatry 16(7), 685, 688-685, 689 (2011).
50. Whalley HC, Sussmann JE, Johnstone M et al. Effects of a mis-sense DISC1 variant on brain activation in two cohorts at high risk of bipolar disorder or schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B(3), 343-353 (2012).
51. Hennah W, Thomson P, Peltonen L, Porteous D. Genes and schizophrenia: beyond schizophrenia: the role of DISC1 in major mental illness. Schizophr. Bull. 32(3), 409-416 (2006).
52. Mata I, Perez-Iglesias R, Roiz-Santiañez R et al. Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. Neuroimage 53(3), 1016-1022 (2010).
53. Nicodemus KK, Callicott JH, Higier RG et al. Evidence of statistical epistasis between DISC1, CIT and NDEL1 impacting risk for schizophrenia: biological validation with functional neuroimaging. Hum. Genet. 127(4), 441-452 (2010).
54. Stefansson H, Sigurdsson E, Steinthorsdottir V et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71(4), 877-892 (2002).
55. Mei L, Xiong WC. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9(6), 437-452 (2008).
56. McIntosh AM, Moorhead TW, Job D et al. The effects of a neuregulin 1 variant on white matter density and integrity. Mol. Psychiatry 13(11), 1054-1059 (2008).
57. Li D, Collier DA, He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum. Mol. Genet. 15(12), 1995-2002 (2006).
58. Corfas G, Roy K, Buxbaum JD. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat. Neurosci. 7(6), 575-580 (2004).
59. Hall J, Whalley HC, Job DE et al. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat. Neurosci. 9(12), 1477-1478 (2006).
60. Law AJ, Lipska BK, Weickert CS et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5́ SNPs associated with the disease. Proc. Natl Acad. Sci. USA 103(17), 6747-6752 (2006).
61. Williams LM, Das P, Harris AW et al. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am. J. Psychiatry 161(3), 480-489 (2004).
62. Johnstone M, Thomson PA, Hall J, McIntosh AM, Lawrie SM, Porteous DJ. DISC1 in schizophrenia: genetic mouse models and human genomic imaging. Schizophr. Bull. 37(1), 14-20 (2011).
63. Mechelli A, Prata DP, Fu CH et al. The effects of neuregulin1 on brain function in controls and patients with schizophrenia and bipolar disorder. Neuroimage 42(2), 817-826 (2008).
64. Zhou SY, Suzuki M, Hagino H et al. Decreased volume and increased asymmetry of the anterior limb of the internal capsule in patients with schizophrenia. Biol. Psychiatry 54(4), 427-436 (2003).
65. Nicodemus KK, Law AJ, Radulescu E et al. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. Arch. Gen. Psychiatry 67(10), 991-1001 (2010).
66. Seshadri S, Kamiya A, Yokota Y et al. Disrupted-in-schizophrenia-1 expression is regulated by β-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc. Natl Acad. Sci. USA 107(12), 5622-5627 (2010).
67. Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A. Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci. 32(9), 485-495 (2009).
68. Wood JD, Bonath F, Kumar S, Ross CA, Cunliffe VT. Disrupted-in- schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain. Hum. Mol. Genet. 18(3), 391-404 (2009).
69. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 2(7992), 924-926 (1976).
70. Meyer-Lindenberg A. Imaging genetics of schizophrenia. Dialogues Clin. Neurosci. 12(4), 449-456 (2010).
71. Viding E, Williamson DE, Hariri AR. Developmental imaging genetics: challenges and promises for translational research. Dev. Psychopathol. 18(3), 877-892 (2006).
72. Casey BJ, Soliman F, Bath KG, Glatt CE. Imaging genetics and development: challenges and promises. Hum. Brain Mapp. 31(6), 838-851 (2010).
73. Whalley HC, Simonotto E, Moorhead W et al. Functional imaging as a predictor of schizophrenia. Biol. Psychiatry 60(5), 454-462 (2006).
74. Blackwood DH, Pickard BJ, Thomson PA, Evans KL, Porteous DJ, Muir WJ. Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1. Neurotox. Res. 11(1), 73-83 (2007).
75. Millar JK, Wilson-Annan JC, Anderson S et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9(9), 1415-1423 (2000).
76. Camargo LM, Collura V, Rain JC et al. Disrupted in Schizophrenia 1 interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol. Psychiatry 12(1), 74-86 (2007).
77. Roffman JL, Weiss AP, Goff DC, Rauch SL, Weinberger DR. Neuroimaginggenetic paradigms: a new approach to investigate the pathophysiology and treatment of cognitive deficits in schizophrenia. Harv. Rev. Psychiatry 14(2), 78-91 (2006).
78. Meyer-Lindenberg A, Nicodemus KK, Egan MF, Callicott JH, Mattay V, Weinberger DR. False positives in imaging genetics. Neuroimage 40(2), 655-661 (2008).
79. Blakely RD, Veenstra-VanderWeele J. Genetic indeterminism, the 5-HTTLPR, and the paths forward in neuropsychiatric genetics. Arch. Gen. Psychiatry 68(5), 457-458 (2011).
80. Walsh T, McClellan JM, McCarthy SE et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320(5875), 539-543 (2008).
81. Stone JL, O'Donovan MC, Gurling H et al. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455(7210), 237-241 (2008).
82. Sebat J, Levy DL, McCarthy SE. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 25(12), 528-535 (2009).
83. Lee J, Park S. Working memory impairments in schizophrenia: a metaanalysis. J. Abnorm. Psychol. 114(4), 599-611 (2005).
84. Blokland GA, McMahon KL, Hoffman J et al. Quantifying the heritability of task-related brain activation and performance during the N-back working memory task: a twin fMRI study. Biol. Psychol. 79(1), 70-79 (2008).
85. Weinberger DR, Egan MF, Bertolino A et al. Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry 50(11), 825-844 (2001).
86. Pomarol-Clotet E, Fatjó-Vilas M, McKenna PJ et al. COMT Val158Met polymorphism in relation to activation and de-activation in the prefrontal cortex: a study in patients with schizophrenia and healthy subjects. Neuroimage 53(3), 899-907 (2010).
87. Krabbendam L, Arts B, van Os J, Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr. Res. 80(2-3), 137-149 (2005).
88. Whalley HC, Simonotto E, Flett S et al. fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia. Brain 127(Pt 3), 478-490 (2004).
89. Demirci O, Calhoun VD. Functional magnetic resonance imaging-implications for detection of schizophrenia. Eur. Neurol. Rev. 4(2), 103-106 (2009).
90. Walter H, Schnell K, Erk S et al. Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Mol. Psychiatry 16(4), 462-470 (2011).
91. Lee SH, DeCandia TR, Ripke S et al.; Schizophrenia Psychiatric Genome-Wide Association Study Consortium (PGCSCZ); International Schizophrenia Consortium (ISC); Molecular Genetics of Schizophrenia Collaboration (MGS). Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat. Genet. 44(3), 247-250 (2012).
92. Walton E, Turner J, Gollub RL et al. Cumulative genetic risk and prefrontal activity in patients with schizophrenia. Schizophr. Bull. doi:10.1093/schbul/sbr190 (2012) (Epub ahead of print).
93. Potkin SG, Turner JA, Fallon JA et al. Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia. Mol. Psychiatry 14(4), 416-428 (2009).